๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Heterogeneity in expression of human leukocyte antigens and melanoma-associated antigens in advanced melanoma

โœ Scribed by Galen A. Ohnmacht; Francesco M. Marincola

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
218 KB
Volume
182
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

โœฆ Synopsis

The study of tumor immunology has led to many innovative therapeutic strategies for the treatment of melanoma. The strategies are primarily dependent on melanoma-associated antigen peptide vaccination or T-cell-based therapy. These immunotherapies are totally reliant on proper copresentation of human leukocyte antigen class I molecules in sufficient quantity and the presence and availability of melanoma-associated antigenic peptides. Altered expression of either HLA class I molecules or melanoma antigens is known to occur. These defects lead to altered manufacture and copresentation of HLA class I molecules with melanoma-associated antigens to T-cells. Defects in any one combination can lead to loss of recognition of melanoma cells and their subsequent destruction by cytotoxic T-lymphocytes. Thus, these immunotherapy strategies can be thwarted by defects or heterogeneity of expression of human leukocyte antigen class I or of melanoma-associated antigens.

๐Ÿ“œ SIMILAR VOLUMES

Heterogeneous expression of melanoma-ass
Heterogeneous expression of melanoma-associated antigens and HLA-A2 in metastatic melanoma in vivo
โœ Janice N. Cormier; Yasmine M. Hijazi; Andrea Abati; Patricia Fetsch; Maria Betti ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 367 KB ๐Ÿ‘ 1 views

MART-1/MelanA and Pmel17/gp100 are melanoma-associated antigens (MAAs) that can be recognized by tumorinfiltrating lymphocytes (TILs) capable of mediating successful adoptive therapy in vivo. Analysis of melanoma cell lines in vitro has demonstrated that heterogeneous antigen expression in the conte

Expression of the melanoma antigen-encod
Expression of the melanoma antigen-encoding gene in human lung cancer
โœ Yoshimatsu, Takashi; Yoshino, Ichiro; Ohgami, Akira; Takenoyama, Mitsuhiro; Hana ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 67 KB ๐Ÿ‘ 2 views

## Background and objectives: We surveyed expression of melanoma antigen-encoding genes in lung cancer because of promising implications for immunotherapy. ## Methods: We studied 57 human lung carcinoma specimens using the reverse transcription-polymerase chain reaction (rt-pcr). ## Results: In

Diverse expansion potential and heteroge
Diverse expansion potential and heterogeneous avidity in tumor-associated antigen-specific T lymphocytes from primary melanoma patients
โœ Belinda Palermo; Rita Campanelli; Stefania Mantovani; Erica Lantelme; Ausilia M. ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 158 KB

While tumor-associated antigen (TAA)-specific CD8(+) T lymphocytes have been detected in metastatic melanoma patients, immune response in early disease phases has not yet been carefully evaluated. We looked for circulating cytotoxic T lymphocytes (CTL) directed against Melan-A / MART1, tyrosinase, g

Expression of transporter associated wit
Expression of transporter associated with antigen processing 1 and 2 (TAP1/2) in malignant melanoma cell lines
โœ Per Thor Straten; Alexei F. Kirkin; Tina Seremet; Jesper Zeuthen ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 108 KB ๐Ÿ‘ 1 views

TAP1 and TAP2 molecules are involved in the transport of peptides prior to their association with class I molecules and are mandatory for efficient antigen presentation. To investigate whether loss of expression of TAP1 or TAP2 is a likely mechanism of immune escape in malignant melanoma, TAP1 and T